Leuprolide_acetate: profile and news

Voyager Pharmaceutical Corporation Adds Six New Board Members Mar 3, 2006
Voyager's most advanced product candidate is Memryte, a proprietary, small, biodegradable implant that is comprised of leuprolide acetate and a polymer, that ... - Carolina Newswire (press release),

New Formulation of Leuprolide Administered Every Six Months Feb 21, 2006
A 12-Month Clinical Study of LA-2585 (45.0 MG): A New 6-Month Subcutaneous Delivery System for Leuprolide Acetate for the Treatment of Prostate Cancer. ... - Cancer Consultants (press release),

Rich Daly Joins TAP As Senior Marketing Executive Feb 2, 2006
...marketing strategy and initiatives for TAP's current and future brands - including Prevacid(R) (lansoprazole) and Lupron Depot(R) (leuprolide acetate for depot ... - International News Service,

Depot Delivery System Maintains Steady Drug Level in Prostate ... Feb 16, 2006
2006 (Reuters Health) - LA-2585 (Atrix Laboratories), an extended release subcutaneous formulation for the long-term delivery of leuprolide acetate, appears to ... - Cancerpage.com,

MediGene’s Prostate Cancer Drug* Launched in France and Other ... Feb 17, 2006
The drug* (active substance: leuprolide acetate) combines standard hormone therapy with a novel, patient-friendly and efficient drug delivery system, the ... - WebWire (press release),

Joseph DeVeaugh-Geiss, MD, Expands Role as Interim Chief Medical ... Jan 16, 2006
...along with the Phase II and Phase III double-blind, placebo-controlled trials (ALADDIN) investigating the safety and effectiveness of leuprolide acetate as a ... - Biotech Intelligence (press release),

CMS Issues Final Rule on Competitive Acquisition of Medicare Part ... Jan 20, 2006
Because all carriers have adopted LCA policies for injectable forms of leuprolide acetate, CMS has not included this product in the CAP. ... - Mondaq News Alerts,

Voyager Pharmaceutical Names Interim Chief Medical Officer Jan 16, 2006
DeVaugh-Geiss has been involved in all three phases of trials for Voyager’s drug leuprolide acetate, which is seen as a potential treatment for Alzheimer’s ... - Local Tech Wire,

Preserving Competition, FTC Requires Divestitures Before Allowing ... Jan 23, 2006
3) pergolide mesylate tablets from Teva, to be divested to Par; 4) estazolam tablets from IVAX, to be divested to Par; 5) leuprolide acetate injection kits ... - PharmaLive.com (press release),

Voyager Pharmaceutical Corporation Announces Revised Terms for IPO Dec 8, 2005
Voyager's most advanced product candidate is Memryte, a proprietary, small, biodegradable implant that is comprised of leuprolide acetate and a polymer, that ... - PharmaLive.com (press release),

Docs Assess Three Therapy Approaches for Poor IVF Responders Nov 30, 2005
The so-called stop protocol at the clinic involved the use of Lupron (leuprolide acetate), a GnRH agonist given during the mid-luteal phase of the patient's ... - Fertility Neighborhood,

MediGene's Drug Eligard® Launched in Spain and Further European ... Nov 15, 2005
Eligard® (active substance: leuprolide acetate) combines standard hormone therapy with a novel, patient-friendly and efficient drug delivery system, the ... - Biotech Intelligence (press release),

Norwood Immunology - Phase II Clinical Trial - Melanoma Cancer ... Nov 17, 2005
...for commercialization in the United States, utilizing TAP's GnRH analogue, Lupron Depot(R) (leuprolide acetate for depot suspension). ... - Business Wire (press release),

A case of raging hormones? Sep 17, 2005
...prostate cancer patient who also had Alzheimer's saw his Alzheimer's symptoms become stabilized after he started taking the drug leuprolide acetate, which has ... - Milwaukee Journal Sentinel,

MediGene's First Drug Eligard® Is Launched Oct 3, 2005
Eligard® (active substance: leuprolide acetate) combines standard hormone therapy with a novel, patient-friendly and efficient drug delivery system, the ... - Biotechnology Investment Today (Press Release),

Devil in the details on Voyager Sep 19, 2005
The company's drug, a previously approved medication called leuprolide acetate that is combined with an undisclosed polymer, has been tested on about 258 ... - MSNBC

Voyager Pharmaceutical Files for Initial Public Offering Sep 9, 2005
Voyager's most advanced product candidate is Memryte, a proprietary, small, biodegradable implant that is comprised of leuprolide acetate and a polymer, that ... - Yahoo! News (press release)

Voyager files for IPO Sep 9, 2005
The company's drug, which is generically called leuprolide acetate, is currently approved to stem the flow of sex hormones and is prescribed for the treatment ... - Bizjournals.com,

TAP Expands Gastroenterological Pipeline by Signing Licensing ... Sep 8, 2005
...of Osaka, Japan. TAP markets Prevacid(R) (lansoprazole) and Lupron Depot(R) (leuprolide acetate for depot suspension). For more ... - PR Newswire (press release),

TAP Expands Gastroenterological Pipeline by Signing Licensing ... Sep 8, 2005
...of Osaka, Japan. TAP markets Prevacid® (lansoprazole) and Lupron Depot® (leuprolide acetate for depot suspension). For more information ... - Yahoo! News (press release)

US FDA Authorizes the Start of a Phase III Multicenter Clinical ... 08 Sep 2005
...on August 25th 2005 the FDA authorized the start in the US of a Phase III multi-center clinical study for it’s depot formulation of Leuprolide Acetate 3,75 mg ... - PharmaLive.com (press release),

TAP Expands Gastroenterological Pipeline by Signing Licensing ... 08 Sep 2005
...of Osaka, Japan. TAP markets Prevacid(R) (lansoprazole) and Lupron Depot(R) (leuprolide acetate for depot suspension). For more ... - PR Newswire (press release),

Company Information Center Sep 1, 2005
...development collaboration with Nektar, which was formed in January 2002, the companies were jointly developing inhaled leuprolide acetate and evaluating other ... - Business Wire (press release),

A Father's Battle With Prostate Cancer Makes His Urologist Son ... Aug 31, 2005
...cancer is manageable; hormonal therapies can help manage the symptoms of the disease, but treatments such as Eligard, or leuprolide acetate for injectable ... - PR Newswire (press release),

American College of Gastroenterology Announces 2005 Junior Faculty ... Aug 16, 2005
...of Osaka, Japan. TAP currently markets Lupron Depot(r) (leuprolide acetate for depot suspension) and Prevacid(r) (lansoprazole). ... - U.S. Newswire (press release),

Norwood Immunology -- Publication in Leading Scientific Journal Aug 11, 2005
...for commercialization in the United States, utilizing TAP's GnRH analogue, Lupron Depot(R) (leuprolide acetate for depot suspension). ... - Genetic Engineering News,

Prostate Cancer Aug 14, 2005
...option. It's called Viadur(r). Viadur is an implant system that contains the hormone medication, leuprolide acetate. The implant ... - WOWT,

Cooking to Reduce the Burn: Heartburn-Friendly Recipes and Tips ... Aug 2, 2005
Limited, of Osaka, Japan. TAP markets Prevacid and Lupron Depot® (leuprolide acetate for depot suspension). For more information ... - Yahoo News (press release) <**results**>

Prostate Cancer Jun 16, 2005
...option. It's called Viadur(r). Viadur is an implant system that contains the hormone medication, leuprolide acetate. The implant ... - WOWT,